Winnipeg Free Press: U of M chemist earns award for work on new drug candidate for treating Lou Gehrig’s disease
November 17, 2025 —
A University of Manitoba PhD candidate with a dramatic life story has been awarded the Mitacs Innovation Award for co-inventing an aspiring new drug candidate for treating amyotrophic lateral sclerosis (ALS), better known as Lou Gehrig’s disease, announced Monday.
To read the full article, please visit Winnipeg Free Press.





